Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease. [electronic resource]
Producer: 20081217Description: 464-5 p. digitalISSN:- 0025-729X
- Adult
- Antibodies, Monoclonal -- adverse effects
- Crohn Disease -- drug therapy
- Fatal Outcome
- Humans
- Immunologic Factors -- adverse effects
- Infliximab
- Liver Neoplasms -- chemically induced
- Lymphoma, T-Cell -- chemically induced
- Male
- Splenic Neoplasms -- chemically induced
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.